Argitalpenak (121) JOSÉ MARÍA ALUNDA RODRÍGUEZ argitalpenak

2024

  1. Antileishmanial and Antitrypanosomes Drugs for the Current Century

    Microorganisms

2023

  1. Design, synthesis and biological evaluation of antiparasitic dinitroaniline-ether phospholipid hybrids

    Bioorganic Chemistry, Vol. 138

  2. Effect of Clindamycin on Intestinal Microbiome and Miltefosine Pharmacology in Hamsters Infected with Leishmania infantum

    Antibiotics, Vol. 12, Núm. 2

2022

  1. First description of Lotmaria passim and Crithidia mellificae haptomonad stages in the honeybee hindgut

    International Journal for Parasitology, Vol. 52, Núm. 1, pp. 65-75

  2. Leishmania infantum infection does not affect the main composition of the intestinal microbiome of the Syrian hamster

    Parasites and Vectors, Vol. 15, Núm. 1

2021

  1. Antileishmanial drug discovery and development: Time to reset the model?

    Microorganisms, Vol. 9, Núm. 12

  2. Scientometric analysis of chemotherapy of canine leishmaniasis (2000–2020)

    Parasites and Vectors, Vol. 14, Núm. 1

2020

  1. Experimental evidence of harmful effects of Crithidia mellificae and Lotmaria passim on honey bees

    International Journal for Parasitology, Vol. 50, Núm. 13, pp. 1117-1124

  2. Infection of dogs by Leishmania infantum elicits a general response of IgG subclasses

    Scientific Reports, Vol. 10, Núm. 1

  3. Molecular characterisation of five Sarcocystis species in domestic sheep (Ovis aries) from Spain

    Parasitology Research, Vol. 119, Núm. 1, pp. 215-231

2019

  1. Accelerating Drug Discovery Efforts for Trypanosomatidic Infections Using an Integrated Transnational Academic Drug Discovery Platform

    SLAS Discovery, Vol. 24, Núm. 3, pp. 346-361

  2. Discovery and Pharmacological Studies of 4-Hydroxyphenyl-Derived Phosphonium Salts Active in a Mouse Model of Visceral Leishmaniasis

    Journal of Medicinal Chemistry, Vol. 62, Núm. 23, pp. 10664-10675

  3. Discovery of a benzothiophene-flavonol halting miltefosine and antimonial drug resistance in Leishmania parasites through the application of medicinal chemistry, screening and genomics

    European Journal of Medicinal Chemistry, Vol. 183

  4. Early antibody response and clinical outcome in experimental canine leishmaniasis

    Scientific Reports, Vol. 9, Núm. 1

  5. Efficient infection of hamster with Leishmania donovani by retro-orbital inoculation

    Virulence

  6. Immunization with recombinant rHc23 partially protects lambs against trickle infections by Haemonchus contortus

    BMC Veterinary Research, Vol. 15, Núm. 1

  7. SAR Studies and Biological Characterization of a Chromen-4-one Derivative as an Anti- Trypanosoma brucei Agent

    ACS Medicinal Chemistry Letters, Vol. 10, Núm. 4, pp. 528-533

  8. Syrian Hamster as an Advanced Experimental Model for Visceral Leishmaniasis

    Methods in Molecular Biology (Humana Press Inc.), pp. 303-314

  9. Vacunación frente a la hemoconsis: un objetivo posible

    Anales de la Real Academia de Ciencias Veterinarias, Vol. 27, Núm. 27, pp. 435-454

2018

  1. In-vitro activity of silybin and related flavonolignans against leishmania infantum and L. donovani

    Molecules, Vol. 23, Núm. 7